Le Lézard
Classified in: Health
Subject: SVY

Insulin Biosimilars - Global Market Outlook (2017-2023)

LONDON, Jan. 11, 2018 /PRNewswire/ -- Stratistics MRC, are pleased to announce the latest publication of Global Insulin Biosimilars market. Growing pervasiveness of type 1 diabetes and ongoing approvals by the government authorities are nurturing the market growth.

Download the full report: https://www.reportbuyer.com/product/4300260

Some of the factors such as growing population exposures, technological developments and favorable medical repayment scenario in developed countries are poised to favour the market growth. However, patent protection rights of insulin and strong vengeance from the key manufacturers are some of the restraints limiting the market.

Expansion of clinically verified insulin biosimilar will cover the road for new entrants. The approaching patent expiration of insulin drugs will unlock new opportunities for the development of biosimilars and manufacturing companies. As cost is high due to strict observance requirements, prices of biosimilar drugs are anticipated to decrease as compared to branded drugs.

North America led the insulin biosimilars market due to rising demand for insulin in the region. Europe is anticipated to account for second largest share and Asia Pacific is expected to grow at a fastest rate during the forecast period. APAC players are competing on the basis of price and have pool of patients affected by diabetes, thus fueling the market growth.

Some of the key players in this market are Wockhardt Limited, Ypsomed AG, Pfizer Inc., Mylan N.V., Boehringer Ingelheim GmbH, NOVO Nordisk A/S, Sanofi S.A., Merck & Co., Biocon Limited and Eli Lilly & Co.

Biosimilars Types Covered:
? Rapid-Acting Biosimilars
? Long-Acting Biosimilars
? Premixed Biosimilars

Disease Indications Covered:
? Type I Diabetes
? Type II Diabetes

Regions Covered:
? North America
o US
o Canada
o Mexico
? Europe
o Germany
o U.K.
o Italy
o France
o Spain
o Rest of Europe
? Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
? South America
o Argentina
o Brazil
o Chile
o Rest of South America
? Middle East & Africa
o Saudi Arabia
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Download the full report: https://www.reportbuyer.com/product/4300260

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: sarah@reportbuyer.com  
Tel: +1 (646) 453 6293
Website: www.reportbuyer.com  

SOURCE ReportBuyer

These press releases may also interest you

at 11:49
American Family Care (AFC), the nation's leading provider of urgent care, accessible primary care, and occupational medicine, announced today it will once again undertake a national campaign to promote flu prevention in the United States. Central to...

at 11:35
Following the Ohio State Board of Pharmacy's proposal to add kratom to the list of Schedule I prohibited drugs, the American Kratom Association (AKA) submitted a petition signed by 22,765 American citizens who support continued access to safe kratom...

at 11:03
Heartland Dental recently announced it will hold its annual Winter Conference event on December 7th and 8th in Orlando, Florida. The event will bring Heartland Dental supported dentists from around the country together to celebrate the year's...

at 11:00
MADISON, Wis., Oct. 19, 2018 /PRNewswire-PRWeb/ -- Healthcare costs continue to skyrocket and remain a significant expense for small farming businesses in Minnesota. A new partnership between TASC, a nation-wide, third-party benefits administrator,...

at 11:00
BALTIMORE, Oct. 19, 2018 /PRNewswire-PRWeb/ -- Innovation and job creation is happening today in the 31 states that have legalized medical cannabis and the 9 recreational states that have legalized recreational cannabis for adult use. As the cannabis...

at 10:50
QED Therapeutics today announced the presentation of positive, updated interim data of infigratinib (BGJ398), an orally administered, selective fibroblast growth factor receptor (FGFR) 1-3 tyrosine kinase inhibitor, for the treatment of advanced or...

News published on 11 january 2018 at 14:27 and distributed by: